TRX2 (trichos=hair in ancient greek; 2=second generation) is one of the world’s leading research projects exclusively devoted to providing a new standard of care for the treatment of Androgenetic Alopecia (AGA). The project has been made possible through Oxford BioLabs Ltd. and former scientists from the University of Oxford, UK.